{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T04:35:38Z","timestamp":1794458138528,"version":"4.9.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>This study aims to analyze risk factors, clinical profiles, treatment protocols, and disease outcomes in histologically proven resectable vulvar cancer (VC) patients according to tumor stage. This is a retrospective analysis of a prospectively collected database of 20 VC patients from May 2014 to June 2019.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean age of VC diagnosis was 55 years, with a range of 38\u201384 years. The incidence was four cases per year. The disease incidence was significantly more in post-menopausal (65%) and multiparous (90%) women. According to FIGO staging of vulvar cancer, stages I, II, and III were assigned to 6, 1, and 11 patients respectively. Two patients suffered from stage IVa vulvar melanoma. All patients had undergone surgical interventions. Patients treated with only nonsurgical (chemotherapy\/radiotherapy\/chemo-radiotherapy) treatment modalities were excluded from the study. Fifteen patients were treated with wide local excision (WLE), bilateral inguinofemoral dissection (B\/L IFLND), and primary repair. Four and one patients were treated with radical vulvectomy (RV) and modified radical vulvectomy (MRV) [with or without B\/L IFLND and PLND] respectively. Reconstruction with V-Y gracilis myocutaneous and local rotation advancement V-Y fasciocutaneous flaps were done in two patients. Therapeutic groin nodal dissection was performed in 19 patients except in one patient who was treated by palliative radical vulvectomy. In the final histopathology reports, tumor size varies from 0.5 to 6.5 cm (mean 3.35 cm) with the predominance of squamous cell carcinoma (18 out of 20 patients). Only 10 out of 18 eligible patients received adjuvant treatment. Poor patient compliance has been one of the major reasons for adjuvant treatment attrition rate. Systemic and loco-regional metastasis occurred in 3 patients each arm respectively. Poor follow up of patients is the key limitation of our study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Vulvar cancer incidence was significantly high in post-menopausal and multiparous women. The most important prognostic factors were tumor stage and lymph node status. Oncological resection should be equated with functional outcome. The multidisciplinary team approach should be sought for this rare gynecological malignancy.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s43046-019-0015-y","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T18:02:39Z","timestamp":1579024959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Vulvar cancer: surgical management and survival trends in a low resource setting"],"prefix":"10.1186","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4059-8153","authenticated-orcid":false,"given":"Navin","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukur Dipi","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. N.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rambha","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanak","family":"Lata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durgesh","family":"Wankhede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoutishman","family":"Saikia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"15_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"15_CR2","first-page":"2133","volume-title":"Cancer: Principles and Practice of Oncology","author":"U Beller","year":"2018","unstructured":"Beller U, Quinn MA, Benedet JL, et al. Carcinoma of the vulva. In: Devita Jr VT, Lawrence TS, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology. 11th ed. Philadelphia: Lippincott Williams &Wilkins; 2018. p. 2133\u201358.","edition":"11"},{"key":"15_CR3","first-page":"633","volume-title":"AJCC Cancer Staging Manual","author":"RK Gibb","year":"2017","unstructured":"Gibb RK, Olawaiye AB, Chen LM, et al. Vulva. In: Amin MB, editor. AJCC Cancer Staging Manual. 8th ed. Chicago: AJCC; 2017. p. 633.","edition":"8"},{"key":"15_CR4","unstructured":"Cancer Stat Facts. Vulvar Cancer, The Surveillance, Epidemiology, and End Results (SEER) Program: National cancer institute; https:\/\/seer.cancer.gov\/statfacts\/html\/vulva.html ; [Last accessed on 2019 Aug 01]."},{"issue":"3","key":"15_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5662\/wjm.v6.i3.187","volume":"6","author":"MD Ray","year":"2016","unstructured":"Ray MD, Garg PK, Jakhetiya A, Kumar S, Pandey D. Modified skin bridge technique for ilio-inguinal lymph node dissection: A forgotten technique revisited. World J Methodol. 2016;6(3):187\u20139.","journal-title":"World J Methodol."},{"issue":"10","key":"15_CR6","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1007\/s00268-018-4604-z","volume":"42","author":"MD Ray","year":"2018","unstructured":"Ray MD, et al. Minimizing Post-Operative Complications of Groin Dissection Using Modified Skin Bridge Technique: A Single-Centre Descriptive Study Showing Post-Operative and Early Oncological Outcomes. World J Surg. 2018;42(10):3196\u2013201.","journal-title":"World J Surg"},{"issue":"Suppl 2","key":"15_CR7","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1016\/S0020-7292(12)60021-6","volume":"119","author":"NF Hacker","year":"2012","unstructured":"Hacker NF, Eifel PJ, van der Veldenc J. FIGO cancer report 2012. Cancer of the vulva. Int J Gynecol Obstet. 2012;119(Suppl 2):S90\u20136.","journal-title":"Int J Gynecol Obstet"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.ygyno.2007.02.014","volume":"105","author":"J Gonzalez Bosquet","year":"2007","unstructured":"Gonzalez Bosquet J, Magrina JF, Magtibay PM, et al. Patterns of inguinal groin metastases in squamous cell carcinoma of the vulva. Gynecol Oncol. 2007;105:742\u20136.","journal-title":"Gynecol Oncol."},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.hoc.2011.10.006","volume":"26","author":"KC Fuh","year":"2012","unstructured":"Fuh KC, Berek JS. Current management of vulvar cancer. Hematol Oncol Clin North Am. 2012;26:45\u201362.","journal-title":"Hematol Oncol Clin North Am"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.gore.2017.02.004","volume":"20","author":"A Kaban","year":"2017","unstructured":"Kaban A, Kaban I, Af\u015far S. Surgical management of squamous cell vulvar cancer without clitoris, urethra or anus involvement. Gynecol Oncol Rep. 2017;20:41\u20136.","journal-title":"Gynecol Oncol Rep"},{"key":"15_CR11","first-page":"76","volume":"6","author":"CA Okolo","year":"2013","unstructured":"Okolo CA, Odubanjo MO, Awolude OA, Akang EE. A review of vulvar and vaginal cancers in Ibadan, Nigeria. N Am J Med Sci. 2013;6:76\u201381.","journal-title":"N Am J Med Sci"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/0002-9378(91)90573-A","volume":"164","author":"HD Homesley","year":"1991","unstructured":"Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A, et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol. 1991;164:997\u20131004.","journal-title":"Am J Obstet Gynecol"},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.4103\/0973-1482.77090","volume":"6","author":"DN Sharma","year":"2010","unstructured":"Sharma DN, Rath GK, Kumar S, Bhatla N, Julka PK, Sahai P. Treatment outcome of patients with carcinoma of vulva: Experience from a tertiary cancer center of India. J Can Res Ther. 2010;6:503\u20137.","journal-title":"J Can Res Ther"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ygyno.2010.01.007","volume":"117","author":"M Courtney-Brooks","year":"2010","unstructured":"Courtney-Brooks M, Sukumvanich P, Beriwal S, Zorn KK, Richard SD, Krivak TC. Does the number of nodes removed impact survival in vulval cancer patients with node negative disease? Gynecol Oncol. 2010;117:308\u201311.","journal-title":"Gynecol Oncol"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2147\/CMAR.S143316","volume":"10","author":"S Mitra","year":"2018","unstructured":"Mitra S, Sharma MK, Kaur I, et al. Vulvar carcinoma: dilemma, debates, and decisions. Cancer Manag Res. 2018;10:61\u20138.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"15_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1006\/gyno.1995.1152","volume":"57","author":"BS Siller","year":"1995","unstructured":"Siller BS, Alvarez RD, Conner WD, McCullough CH, Kilgore LC, Partridge EE, Austin J. T2\/3 Vulva Cancer: A Case-Control Study of Triple Incision versus en Bloc Radical Vulvectomy and Inguinal Lymphadenectomy. Gynecologic Oncol. 1995;57(3):335\u20139.","journal-title":"Gynecologic Oncol"},{"key":"15_CR17","doi-asserted-by":"crossref","unstructured":"Shylasree TS, Bryant A, Howells REJ. Chemoradiation for advanced primary vulval cancer. Cochrane Database Syst Rev 2011;Issue 4. Art. No.: CD003752.","DOI":"10.1002\/14651858.CD003752.pub3"},{"key":"15_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ygyno.2011.11.003","volume":"124","author":"DH Moore","year":"2012","unstructured":"Moore DH, Ali S, Koh WJ, Michael H, Barnes MN, McCourt CK, Homesley HD, Walker JL. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: A gynecologic oncology group study. Gynecol Oncol. 2012;124:529\u201333.","journal-title":"Gynecol Oncol."},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.ijrobp.2012.11.012","volume":"85","author":"S Beriwal","year":"2013","unstructured":"Beriwal S, Shukla G, Shinde A, Heron DE, Kelley JL, Edwards RP, Sukumvanich P, Richards S, Olawaiye AB, Krivak TC. Preoperative intensity modulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: Analysis of pattern of relapse. Int J Radiat Oncol Biol Phys. 2013;85:1269\u201374.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"4","key":"15_CR20","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3892\/ol.2012.831","volume":"4","author":"A Gaudineau","year":"2012","unstructured":"Gaudineau A, Weitbruch D, Quetin P, Heymann S, Petit T, Volkmar P, et al. Neoadjuvant chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the vulva. Oncology letters. 2012;4(4):719\u201322.","journal-title":"Oncology letters."},{"key":"15_CR21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4103\/0019-509X.200656","volume":"53","author":"N Singh","year":"2016","unstructured":"Singh N, Negi N, Srivastava K, Agarwal G. A cohort study of vulvar cancer over a period of 10 years and review of literature. Indian J Cancer. 2016;53:412\u20135.","journal-title":"Indian J Cancer"},{"issue":"5","key":"15_CR22","first-page":"555741","volume":"8","author":"DK Rajshree","year":"2018","unstructured":"Rajshree DK, Kothari TO, Mahesh SR. Vulvar carcinoma survival outcome: an institutional experience. Canc Therapy Oncol Int J. 2018;8(5):555741.","journal-title":"Canc Therapy Oncol Int J"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"4723167","DOI":"10.1155\/2018\/4723167","volume":"2018","author":"P Meelapkij","year":"2018","unstructured":"Meelapkij P, Suprasert P, Baisai O. Treatment outcomes of patients with squamous cell carcinoma of the vulva: the largest series from a tertiary care hospital. Obstet Gynecol Int. 2018;2018:4723167.","journal-title":"Obstet Gynecol Int"},{"key":"15_CR24","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/ijc.30621","volume":"140","author":"P Halonen","year":"2017","unstructured":"Halonen P, Jakobsson M, Heikinheimo O, Riska A, Gissler M, Pukkala E. Lichen sclerosus and risk of cancer. Int J Cancer. 2017;140:1998\u20132002.","journal-title":"Int J Cancer."},{"key":"15_CR25","first-page":"74","volume":"15","author":"AR Palumbo","year":"2016","unstructured":"Palumbo AR, Fasolino C, Santoro G, et al. Evaluation of symptoms and prevention of cancer in menopause: the value of vulvar exam. Transl Med UniSa. 2016;15:74\u20139.","journal-title":"Transl Med UniSa."}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-019-0015-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s43046-019-0015-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-019-0015-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T03:17:12Z","timestamp":1695611832000},"score":1,"resource":{"primary":{"URL":"https:\/\/jenci.springeropen.com\/articles\/10.1186\/s43046-019-0015-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["15"],"URL":"https:\/\/doi.org\/10.1186\/s43046-019-0015-y","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,14]]},"assertion":[{"value":"8 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. As this study is a retrospective observational study and treatment of patients had finished before the start of the study. Also, few patients of our study are not under follow up, due to default status or succumbed to the disease.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Authors give full consent to the publisher, including reading, editing for the publication of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}